日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Child participation during outpatient consultations: a mixed methods study

儿童参与门诊就诊:一项混合方法研究

Koenis, Maud M; Vroman, Heleen; Brand, Paul L P; van Woerden, Christiaan S

Continuous vital sign monitoring in patients after elective abdominal surgery: a retrospective study on clinical outcomes and costs

择期腹部手术后患者持续生命体征监测:一项关于临床结果和成本的回顾性研究

Vroman, Heleen; Mosch, Diederik; Eijkenaar, Frank; Naujokat, Elke; Mohr, Belinda; Medic, Goran; Swijnenburg, Marcel; Tesselaar, Eric; Franken, Martijn

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.

对间皮瘤患者的免疫监测发现了吉西他滨与临床反应相关的新型免疫调节功能

Dammeijer Floris, De Gooijer Cornedine J, van Gulijk Mandy, Lukkes Melanie, Klaase Larissa, Lievense Lysanne A, Waasdorp Cynthia, Jebbink Merel, Bootsma Gerben P, Stigt Jos A, Biesma Bonne, Kaijen-Lambers Margaretha E H, Mankor Joanne, Vroman Heleen, Cornelissen Robin, Baas Paul, Van der Noort Vincent, Burgers Jacobus A, Aerts Joachim G

Tnfaip3 expression in pulmonary conventional type 1 Langerin-expressing dendritic cells regulates T helper 2-mediated airway inflammation in mice

小鼠肺部常规1型朗格林表达树突状细胞中Tnfaip3的表达调节T辅助细胞2介导的气道炎症。

Vroman, Heleen; van Uden, Denise; Bergen, Ingrid M; van Hulst, Jennifer A C; Lukkes, Melanie; van Loo, Geert; Clausen, Björn E; Boon, Louis; Lambrecht, Bart N; Hammad, Hamida; Hendriks, Rudi W; Kool, Mirjam

Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials

纳武利尤单抗和伊匹木单抗治疗恶性胸膜间皮瘤患者的疗效与效应记忆细胞毒性T细胞亚型相关:来自两项临床试验的转化证据

Mankor, Joanne M; Disselhorst, Maria J; Poncin, Myrthe; Baas, Paul; Aerts, Joachim G J V; Vroman, Heleen

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

树突状细胞疫苗接种和CD40激动剂联合疗法可在胰腺癌小鼠模型中诱导T细胞依赖性抗肿瘤免疫。

Lau, Sai Ping; van Montfoort, Nadine; Kinderman, Priscilla; Lukkes, Melanie; Klaase, Larissa; van Nimwegen, Menno; van Gulijk, Mandy; Dumas, Jasper; Mustafa, Dana A M; Lievense, Sanne L A; Groeneveldt, Christianne; Stadhouders, Ralph; Li, Yunlei; Stubbs, Andrew; Marijt, Koen A; Vroman, Heleen; van der Burg, Sjoerd H; Aerts, Joachim; van Hall, Thorbald; Dammeijer, Floris; van Eijck, Casper H J

T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma

免疫治疗前后T细胞受体库的特征与间皮瘤的临床反应相关

Vroman, Heleen; Balzaretti, Giulia; Belderbos, Robert A; Klarenbeek, Paul L; van Nimwegen, Menno; Bezemer, Koen; Cornelissen, Robin; Niewold, Ilse T G; van Schaik, Barbera D; van Kampen, Antione H; Aerts, Joachim G J V; de Vries, Niek; Hendriks, Rudi W

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment

利用免疫调节常规疗法增强树突状细胞疗法在实体瘤中的应用

Belderbos, Robert A; Aerts, Joachim G J V; Vroman, Heleen

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

一项多中心、随机、II/III期临床研究,旨在评估负载异体肿瘤细胞裂解物(MesoPher)的树突状细胞作为间皮瘤患者化疗后维持治疗的疗效:间皮瘤树突状细胞免疫疗法(DENIM)试验

Belderbos, Robert A; Baas, Paul; Berardi, Rossana; Cornelissen, Robin; Fennell, Dean A; van Meerbeeck, Jan P; Scherpereel, Arnaud; Vroman, Heleen; Aerts, Joachim G J V

Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy

低剂量环磷酰胺可清除恶性胸膜间皮瘤患者循环中的初始和活化调节性T细胞,并与基于树突状细胞的免疫疗法产生协同作用。

Noordam, Lisanne; Kaijen, Margaretha E H; Bezemer, Koen; Cornelissen, Robin; Maat, Lex A P W M; Hoogsteden, Henk C; Aerts, Joachim G J V; Hendriks, Rudi W; Hegmans, Joost P J J; Vroman, Heleen